Trade Summary

3 days ago, Carr Edward, serving as CHIEF ACCOUNTING OFFICER at Dianthus Therapeutics, Inc. /De/ (DNTH), sold 43,682 shares at $81.49 per share, for a total transaction value of $3,559,495.00.

This sale represents a 100.00% decrease in Carr Edward's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, March 12, 2026 and publicly disclosed via SEC Form 4 filing on Friday, March 13, 2026, 1 day after the trade was made.

Dianthus Therapeutics, Inc. /De/ operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.